Posted Jul. 11, 2013 at 7:25 a.m.

Premium Lock Heat Biologics IPO target increased to $33M

Published: 2013-07-11 07:25:10
Updated: 2013-07-11 07:25:10

Heat Biologics' ImPACT process Heat Biologics' ImPACT process

Heat Bio expects net proceeds of $22.5 million, which it would use to finance clinical trials on its two lead cancer treatments....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders